As of April 16, 2026, the CDC reports 1,748 confirmed measles cases in the United States this year across 33 jurisdictions, with 94% outbreak-associated amid 19 new outbreaks—primarily in South Carolina, Texas, Utah, Arizona, and Florida—and 92% occurring in unvaccinated individuals or those with unknown vaccination status. This highly contagious paramyxovirus, with an R0 of 12–18, exploits declining MMR vaccination coverage below the 95% herd immunity threshold in many communities, fueled by international importations and sustained local transmission. Trader consensus reflects this surge, surpassing early-year totals from prior outbreaks; key variables include school reopenings and travel volumes. Watch for CDC's weekly case updates and Morbidity and Mortality Weekly Reports (MMWR), plus any Pan American Health Organization reviews of U.S. elimination status, expected mid-year.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于$7,603,430 交易量
$7,603,430 交易量
2026-12-31
↑2千
99%
↑3千
83%
↑4千
50%
↑5千
33%
↑7.5k
14%
↑1万
13%
↑1.25万
9%
$7,603,430 交易量
$7,603,430 交易量
2026-12-31
↑2千
$40,123 交易量
99%
↑3千
$45,631 交易量
83%
↑4千
$149,107 交易量
50%
↑5千
$206,577 交易量
33%
↑7.5k
$160,132 交易量
14%
↑1万
$6,483,838 交易量
13%
↑1.25万
$343,513 交易量
9%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 16, 2026, the CDC reports 1,748 confirmed measles cases in the United States this year across 33 jurisdictions, with 94% outbreak-associated amid 19 new outbreaks—primarily in South Carolina, Texas, Utah, Arizona, and Florida—and 92% occurring in unvaccinated individuals or those with unknown vaccination status. This highly contagious paramyxovirus, with an R0 of 12–18, exploits declining MMR vaccination coverage below the 95% herd immunity threshold in many communities, fueled by international importations and sustained local transmission. Trader consensus reflects this surge, surpassing early-year totals from prior outbreaks; key variables include school reopenings and travel volumes. Watch for CDC's weekly case updates and Morbidity and Mortality Weekly Reports (MMWR), plus any Pan American Health Organization reviews of U.S. elimination status, expected mid-year.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
市场开放时间： Dec 1, 2025, 12:56 PM ET
交易量
$7,603,430结束日期
2026-12-31市场开放时间
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 16, 2026, the CDC reports 1,748 confirmed measles cases in the United States this year across 33 jurisdictions, with 94% outbreak-associated amid 19 new outbreaks—primarily in South Carolina, Texas, Utah, Arizona, and Florida—and 92% occurring in unvaccinated individuals or those with unknown vaccination status. This highly contagious paramyxovirus, with an R0 of 12–18, exploits declining MMR vaccination coverage below the 95% herd immunity threshold in many communities, fueled by international importations and sustained local transmission. Trader consensus reflects this surge, surpassing early-year totals from prior outbreaks; key variables include school reopenings and travel volumes. Watch for CDC's weekly case updates and Morbidity and Mortality Weekly Reports (MMWR), plus any Pan American Health Organization reviews of U.S. elimination status, expected mid-year.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,603,430结束日期
2026-12-31市场开放时间
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of April 16, 2026, the CDC reports 1,748 confirmed measles cases in the United States this year across 33 jurisdictions, with 94% outbreak-associated amid 19 new outbreaks—primarily in South Carolina, Texas, Utah, Arizona, and Florida—and 92% occurring in unvaccinated individuals or those with unknown vaccination status. This highly contagious paramyxovirus, with an R0 of 12–18, exploits declining MMR vaccination coverage below the 95% herd immunity threshold in many communities, fueled by international importations and sustained local transmission. Trader consensus reflects this surge, surpassing early-year totals from prior outbreaks; key variables include school reopenings and travel volumes. Watch for CDC's weekly case updates and Morbidity and Mortality Weekly Reports (MMWR), plus any Pan American Health Organization reviews of U.S. elimination status, expected mid-year.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题